Security key
74449F209
PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM)
CUSIP: 74449F209
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Shares, without par value
- Total 13F shares
- 455,006
- Total 13F value
- $272,834
- Share change
- -294,864
- SEC-reported price per share
- $0.60
- Number of holders
- 8
- Value change
- -$1,162,584
- Number of buys
- 8
- Number of sells
- 7
- Shares outstanding
- 4,527,832
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
8
Top holders
8
PBM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
PSYENCE BIOMEDICAL LTD. SEC filings
PSYENCE BIOMEDICAL LTD. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74449F209
Recent filing periods:
Ownership snapshot
Top reported holders of PBM - PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Psyence Group Inc.
Disclosed value leader
Hudson Bay Capital Manage...
Comparable rows
11/15
Latest evidence
25 Mar 2025
13D/G
13F
Lead comparable stake: 15%
4 rows are not safely comparable across share classes.
13D/G row: Psyence Group Inc.
Showing 1-6 of 15 holder rows.
Quick read
Psyence Group Inc. leads the comparable SEC ownership view at 15%.
11 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Psyence Group Inc.'s linked filing trail.
Comparable ownership
Top 5
Psyence Group Inc.
15%
Hudson Bay Capital Management LP
5%
AdvisorShares Trust
0.79%
Essential Planning, LLC.
1.6%
AdvisorShares Investments LLC
0.59%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Psyence Group Inc. |
13D/G
|
15%
|
$380,084
678,722 shares
|
$0 | 25 Mar 2025 |
| Hudson Bay Capital Management LP |
13F
13D/G
Company
|
5%
from 13D/G
|
$743,670
380,000 shares
|
— | 31 Dec 2024 |
| AdvisorShares Trust |
13D/G
|
0.79%
|
$15,077
26,924 shares
|
$0 | 31 Dec 2024 |
| Essential Planning, LLC. |
13F
Company
|
1.6%
|
$162,605
73,278 shares
|
— | 31 Dec 2024 |
| AdvisorShares Investments LLC |
13F
Company
|
0.59%
|
$56,808
26,923 shares
|
— | 31 Dec 2024 |
| HRT FINANCIAL LP |
13F
Company
|
0.58%
|
$55,000
26,127 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
455,006
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
11
Q1 2025 holders
8
Holder diff
-3
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend